Rx/Reimbursement Adult Incontinence in Brazil
Description
Rx/reimbursement adult incontinence in Brazil delivered a notable performance in 2025, with volumes reaching 122 million units, representing a year-on-year increase of 6%. This outpaced the previous year’s 2% growth and was stronger than the average trend observed in Latin America, reflecting the direct impact of domestic public health policies. The underlying demographic trend also boosted demand, with the population aged 65+ reaching 24.3 million in 2025, up by a million from the previous year...
Euromonitor International's Rx/Reimbursement adult incontinence in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2021-2025, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2030 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International's Rx/Reimbursement adult incontinence in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2021-2025, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2030 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
31 Pages
- Rx/Reimbursement Adult Incontinence in Brazil
- Euromonitor International
- April 2026
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN BRAZIL
- Key Data Insights
- 2025 Developments
- Farmácia Popular Expansion Drives Volume-Led Growth
- Key Industry Trends
- CHART 1 Key Industry Trends for Rx/Reimbursement Adult Incontinence
- Industry Performance
- CHART 2 Farmácia Popular Expands Free Adult Incontinence Supplies Under Health System SUS in 2025
- Bigfral’S Inclusive Approach Boosts Access and Improves Patient Fit
- CHART 3 Bigfral Expands Size-Inclusive Adult Incontinence Portfolio Supplied Via Reimbursed Pharmacies
- CHART 4 Value Sales 2020-2030
- CHART 5 Volume Sales 2020-2030
- What's Next?
- Continued Dynamism as the Population Ages and the Consumer Base Expands
- Performance Will Be Linked to Public Policy Decisions
- Pharmacy Networks to Strengthen Access and Drive Supplier Strategies
- CHART 6 Forecast Value Sales 2020-2030
- Economic Context
- CHART 7 Economic Context for Rx/Reimbursement Adult Incontinence
- CHART 8 Real Gdp Growth 2020-2030
- CHART 9 Inflation 2020-2030
- Consumer Context
- CHART 10 Consumer Context for Rx/Reimbursement Adult Incontinence
- CHART 11 Population 2020-2030
- CHART 12 Consumer Expenditure 2020-2030
- CHART 13 Population by Generation 2025
- Country Reports Disclaimer
- CHART 14 Key Industry Trends for Tissue and Hygiene
- CHART 15 Bracell Amplifies its Presence with Affordable Toilet Paper, Focusing on Cost-Benefit Ratio
- CHART 16 Always Launches Pocket Flexfoam to Offer Compact Convenience in Menstrual Care
- CHART 17 Dermacyd launches Neutralize intimate wipes with pH-balanced Odor Control technology
- CHART 18 Value Sales 2020-2030
- CHART 19 Value Sales by Category 2025
- CHART 20 Analyst Insight for Tissue and Hygiene
- CHART 21 Forecast Value Sales 2020-2030
- CHART 22 Forecast Value Sales by Category 2025-2030
- CHART 23 Company Shares 2025
- CHART 24 Brand Shares 2025
- CHART 25 Retail Channels 2020-2025
- CHART 26 Economic Context for Tissue and Hygiene
- CHART 27 Real Gdp Growth 2020-2030
- CHART 28 Inflation 2020-2030
- CHART 29 Consumer Context for Tissue and Hygiene
- CHART 30 Population 2020-2030
- CHART 31 Consumer Expenditure 2020-2030
- CHART 32 Population by Generation 2025
- TISSUE AND HYGIENE IN BRAZIL
- Executive Summary
- Bracell Expands Affordable Tissue Lines to Capture Price-Sensitive Shoppers
- Key Data Insights
- Key Industry Trends
- Industry Performance
- Retail Tissue Maintains Lead as Bulk Formats and Value Brands Drive Volumes
- Always Launches Pocket Flexfoam to Drive Convenience-Led Premium Growth
- Dermacyd Targets Clean Wellness with Ph-Balanced Intimate Wipes
- What's Next?
- Adult Incontinence Providers to Leverage the Ageing Population to Drive Adoption
- Value Brands to Remain Significant Due to Persistent Price Sensitivity
- Omnichannel Strategies and Monitoring and Adapting to Regulations Will Be Important for Companies
- Competitive Landscape
- Kimberly-Clark Maintains Its Lead, but the Competition Rises in the Value Segment
- Softys' Acquisition of Ontex's Brazilian Business Impacts Tissue and Hygiene
- Aggressive Expansion Positions Bracell as a Major Challenger
- Channels
- Health and Beauty Specialists Captures Hygiene Sales as Shoppers Seek Advice and Chains Expand
- Retail E-Commerce Gains Ground for Premium and Bulk Products, but Rises From a Low Base
- Economic Context
- Consumer Context
- Country Reports Disclaimer
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
